Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Report! Call 1-800-clownpolice
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by PROtradingon Apr 16, 2017 12:59pm
148 Views
Post# 26125522

Report! Call 1-800-clownpolice

Report! Call 1-800-clownpoliceIf you need to report the multialias clowns on this carnival of a discussion site, please call 1-800-clownpolice.

You'll have as much success as doing it here with the "whack a mole" game!   LOL

Seriously, good luck trying to get much good discussion around this flaming dumpster!  Don't stand too close, it's going to melt your easter eggs!

User image
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities